Category : Search result: biosimilars integration


Biocon Integrates Biologics Arm in $5.5 Billion Share Swap

Biocon announces full integration of its biosimilars unit, Biocon Biologics, in a deal valuing it at $5.5 billion. The move aims to create a unified powerhouse in diabetes, oncology, and immunology markets. Read more.

Harlem Globetrotters' 100-Year Journey of Hoops & Hope

As the Harlem Globetrotters begin their 100-year tour, we look at how they broke racial barriers, became US soft power icons, and inspired millions, including Barack Obama. Discover their incredible story.

MP Students Complete Cultural Exchange in Nagaland

A 35-member Samagra Shiksha delegation from Madhya Pradesh concluded a four-day cultural and educational exchange tour in Nagaland, fostering national integration through Ek Bharat Shrestha Bharat programme.

Lupin: Undervalued Pharma Giant at 21x P/E?

Lupin stocks trade at 21.7x P/E despite record earnings and 80 new products pipeline. Discover why this pharma giant might be undervalued and poised for next growth cycle with biosimilars and complex generics.

AI Bubble Risk: Taxpayers May Face Bailout Burden

As AI becomes essential in healthcare, education and finance, taxpayers could face massive bailout costs if the AI bubble bursts, mirroring the 2008 financial crisis. Learn about the risks.

SBI to Modernize Core Banking in 2 Years

State Bank of India reveals ambitious 2-year plan to transform legacy banking systems through hardware upgrades, open-source migration & microservices. Discover how this affects you.

Page 1 of 3